Martin Dow
 | |
| Company type | Private |
|---|---|
| Industry | Pharmaceutical |
| Founded | 1995 |
| Founder | Jawed Akhai |
| Headquarters | Karachi, Pakistan |
| Products | Enflor, Duvel Plus, Rocephin, Cal One-D, Rivotril, Musidin, Lexotanil, Inspra, Esomax, Dilatrend, Elixaban, Orpase, Dowmoxi, Safepram, Kytril, Bon One, Malcifer-F, Fusiderm, Terbin, Dormicum, Dowmoxi,Orzit,Inspra, Dowfylin, Valium |
| Revenue |  Rs. 2618.6 crore (US$91 million) (2021)[1] |
Number of employees | 1,000+ [2] |
| Subsidiaries | Seatle (Pvt.) Ltd., Martin Dow Marker, Martin Dow Healthcare, Martin Dow Pharmaceuticals |
| Website | martindow martindow |
Martin Dow is a Pakistani multinational pharmaceutical company which is based in Karachi. It was founded in 1995[3][4] and has six manufacturing facilities in Pakistan[5] and one in France.[6]
History
[edit]Martin Dow was founded in 1995 and began operations in 2000 with a small manufacturing facility in Lahore.[7]
In 2010, Martin Dow acquired the manufacturing facility and brands of Roche Pakistan.[8]
In 2015, Martin Dow was recognized as a Global Growth Company by the World Economic Forum.[9] In the same year, Martin Dow entered into an alliance with Biocodex S.A., a France-based pharmaceutical company.[10]
In 2016, German Merck KGaA executed a binding contract to divest its shareholding in Pakistan to Martin Dow Ltd.[11][12][13]
In 2016, in a €1.5 million deal, Martin Dow acquired the Laboratoires Salem (before 2010 Bristol-Myers Squibb) pharmaceutical manufacturing facility in Meymac, France.[14][15] In March 2017, the French President Francois Hollande inaugurated Martin Dow Pharma's Meymac Plant in France.[16][17] The plant of V2Pharm in Gien, France, was also taken over by Martin Dow.[18]
In 2020, Martin Dow was awarded for excellent performance in fire safety and protection by the Sindh Local Government minister.[19]
Controversy
[edit]In 2016, the National Accountability Bureau (NAB) arrested two directors of Martin Dow because it wrongfully derived financial benefits on the basis of illegal price increase.[20][21][22]
References
[edit]- ^ "Martin Dow Limited" (PDF). The Pakistan Credit Rating Agency Limited. Retrieved 29 February 2024.
- ^ "CORPORATE PROFILE". Martin Dow. Retrieved 31 December 2016.
- ^ "Pakistani pharmaceutical company to operate in France". Business Recorder. 21 August 2016. Retrieved 30 December 2016.
Martin Dow was established in 1995 initially as a pharmaceutical marketing company in Karachi (Pakistan)
- ^ "Martin Dow - Corporate Profile". Martin Dow.
- ^ Hussain, Dilawar (21 November 2016). "A strategic relationship". Dawn. Retrieved 31 December 2016.
With the acquisition of Merck Pakistan, Martin Dow will have six manufacturing facilities in the country.
- ^ Mettis, Global (29 March 2019). "Martin Dow Pakistan adds state of art manufacturing facility in France". Mettis Global Link. Retrieved 22 August 2024.
- ^ Baig, Mariam Ali (23 April 2021). "Interview: Javed Ghulam Mohammad, Group MD & CEO, Martin Dow Group". Aurora Magazine.
- ^ "Martin Dow - Company Profile". Business Recorder. 15 July 2012. Retrieved 28 December 2016.
- ^ "List of Global Growth Company Members" (PDF). World Economic Forum. Retrieved 30 December 2016.
- ^ "Treating illness: Martin Dow, Biocodex ink alliance". Express Tribune. 12 March 2015. Retrieved 2 January 2017.
- ^ "German pharma giant divests interests". The Express Tribune. PPI. 8 November 2016. Retrieved 28 December 2016.
- ^ "Merck divests its Pakistan stake to Martin Dow". Dawn. 8 November 2016. Retrieved 28 December 2016.
- ^ "Martin Dow acquires Merck operations in Pakistan". The News International. 8 November 2016. Retrieved 28 December 2016.
- ^ "Pakistani pharmaceutical company to operate in France". Business Recorder. 21 August 2016. Retrieved 30 December 2016.
A Pakistani Pharmaceutical company, Martin Dow has acquired a pharmaceutical manufacturing facility in Meymac, France. The facility was earlier owned by the renowned pharmaceutical firm Bristol-Myers Squibb.
- ^ Mérigaud, Corinne (3 December 2015). "Laboratoires Salem repris par le pakistanais Martin Dow". L'Usine Nouvelle. Retrieved 30 December 2016.
- ^ "French President to inaugurate Pakistani Pharma Plant in France". The Nation. Retrieved 3 January 2017.
- ^ "Inauguration of Martin Dow plant by the French President (Meymac, 16 March 2017)". La France au Pakistan - Ambassade de France au Pakistan. Retrieved 1 April 2019.
- ^ "L'ancien site de V2Pharm à Gien va être repris". La Republique. 1 July 2015. Retrieved 3 January 2017.
- ^ "Sindh LG Minister Nasir Shah gives Fire Safety Awards to 43 companies". Daily Times. 22 December 2020. Retrieved 1 January 2021.
- ^ "Drug business: NAB arrests 8 involved in mega corruption". The Express Tribune. 23 November 2016.
- ^ "NAB arrests eight in drug price-hike cases". The Nation. 23 November 2016.
- ^ "NAB arrests top bureaucrat in illegal drugs price hike case". Daily Times (Pakistan). 25 November 2016.